In this study, we confirm that BTG2 is frequently down-regulated in renal cell carcinoma (RCC) tissues and its low expression is associated with unfavorable prognosis and decreased m6A level. The gene discussed is BTG2; the disease is hereditary clear cell renal cell carcinoma.